Skip to content

Sartorius Stedim Biotech SA Sustainability Reports

The company provides equipment and services for the biopharmaceutical industry to manufacture biotech medications safely and efficiently. Its portfolio covers cell line technologies, cell culture media, bioreactors, and single-use fluid management solutions.

Sector: Manufacturing

Country: France

Exchange: Euronext Paris

ISIN: FR0013154002

22 reports from 2007 to 2025